Learn More
Medchemexpress LLC Vociprotafib | 2172652-48-9 | 99.7% | C20H27ClN6O2S | 50 MG

Supplier: Medchemexpress LLC HY14152350MG
Vociprotafib is an orally active, selective, and potent phosphatase SHP2 inhibitor. It blocks the activation of the RAS-RAF-MEK-ERK signaling pathway, demonstrating antitumor activity. It has been shown to accelerate tumor regressions in Osimertinib-sensitive EGFR-mutant tumors in mice and delays or reduces tumor regrowth upon cessation of treatment.
- Selective and potent SHP2 inhibitor
- Blocks RAS-RAF-MEK-ERK signaling pathway activation
- Accelerates tumor regressions in Osimertinib-sensitive EGFR-mutant tumors
- Delays and/or reduces tumor regrowth
- Effective in PDX models with resistance to Osimertinib via c-MET amplification
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.